BeiGene de­cides not to li­cense DKK1 drug, but keeps PD-1 com­bo tri­al in gas­tric can­cer

3 years ago
Deals

Mod­er­na's 'sur­prise' IP court or­der could set up a big set­tle­ment for Roivant, Ar­bu­tus — an­a­lysts

3 years ago
Law

Pfiz­er, Astel­las tout pos­i­tive PhI­II da­ta to po­ten­tial­ly ex­pand Xtan­di la­bel

3 years ago
R&D

Ul­tragenyx adds new CMO with in­ter­nal pro­mo­tion; Au­to­lus CFO to leave for Mor­phoSys — but not quite yet

3 years ago
Peer Review

In re­ver­sal, Sarep­ta to face FDA’s pan­el of out­side ex­perts on Duchenne gene ther­a­py

3 years ago
Cell/Gene Tx
FDA+

Am­gen cites in­fla­tion, pres­sure on drug prices in 450-per­son lay­off

3 years ago
People
Pharma

FDA ad­comm votes in fa­vor of Pfiz­er's Covid-19 pill Paxlovid

3 years ago
Pharma
FDA+

Mer­ck­'s Keytru­da plus TIG­IT com­bo proves less ef­fec­tive than chemo in open-la­bel lung can­cer study

3 years ago
R&D
Pharma

Three­'s com­pa­ny: Sanofi fol­lows lead of Lil­ly and No­vo, slash­es in­sulin price by 78% and caps out-of-pock­et costs

3 years ago
Pharma

SEC says Eli Lil­ly can't avoid re­quests for more in­fo on di­ver­si­ty ef­forts, abor­tion stance

3 years ago
Pharma

Vi­iV's newest cam­paign aims to nor­mal­ize sex and health dis­cus­sions to help HIV pre­ven­tion among Black women

3 years ago
Pharma
Marketing

Ab­b­Vie-spon­sored eczema doc­u­men­tary de­buts at South by South­west

3 years ago
Pharma
Marketing

Dr. Red­dy’s di­vests $33M worth of der­ma­tol­ogy brands in In­dia

3 years ago
Deals
Pharma

No­vo Nordisk sus­pend­ed from lead­ing UK trade group over obe­si­ty mar­ket­ing 'breach'

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: New Hous­ton-based bio­man­u­fac­tur­ing site com­ing; UK cell and gene ther­a­py cen­ter opens

3 years ago
Manufacturing

LG Chem nets $200M con­tract to man­u­fac­ture sev­er­al vac­cines

3 years ago
Manufacturing

Con­tract man­u­fac­tur­ers BioCi­na and Genezen name new CEOs

3 years ago
People
Manufacturing

Im­munome stops Covid-19 work; Hookipa drops CMV vac­cine

3 years ago
News Briefing

Seagen qui­et­ly doles out cell ther­a­py patent rights, but scope re­mains un­clear

3 years ago
Deals
Cell/Gene Tx

'Very re­al' head­winds: With lean­er staff, can­cer vac­cine mak­er search­es for help

3 years ago
Financing
R&D

In ‘sur­prise’ move, BioX­cel files for can­cer sub­sidiary to go pub­lic

3 years ago
Financing
R&D

CMS ex­plains how it will ne­go­ti­ate the most ex­pen­sive drug prices with bio­phar­ma be­gin­ning in 2026

3 years ago
Pharma
Law

Medicxi backs siR­NA-fo­cused Alde­na Ther­a­peu­tics with $30M

3 years ago
Financing

Roy­al­ty Phar­ma nabs $475M mile­stone from Pfiz­er up­on mi­graine nasal spray OK

3 years ago
Deals
First page Previous page 360361362363364365366 Next page Last page
A service from the Financial Times